论文部分内容阅读
目的评价蚓激酶联合阿托伐他汀钙治疗短暂性脑缺血发作的有效性和安全性。方法将短暂性脑缺血发作患者60例,随机分为治疗组、对照组各30例,两组均采用抗血小板聚集、活血化瘀等治疗,治疗组加服蚓激酶胶囊及阿托伐他汀钙片,比较其疗效。结果比较短暂脑缺血发作经治疗后的转归,治疗组优于对照组,有显著差异,且均未出现出血病例。结论蚓激酶联合阿托伐他汀钙治疗短暂性脑缺血发作是安全有效的。
Objective To evaluate the efficacy and safety of lumbrokinase in combination with atorvastatin calcium in the treatment of transient ischemic attacks. Methods Sixty patients with transient ischemic attack were randomly divided into treatment group (n = 30) and control group (n = 30). The two groups were treated with anti-platelet aggregation and activating blood circulation and removing blood stasis. The treatment group received lumbrokinase capsules and atorvastatin Calcium, compare its efficacy. Results Compared with the outcome after the treatment of transient ischemic attack, the treatment group was superior to the control group, with significant differences, and no bleeding occurred. Conclusion Lumbrokinase combined with atorvastatin calcium is safe and effective in treating transient ischemic attack.